StockpollyBeta
Get App
Popularity #288
NTRA · NASDAQ · Medical - Diagnostics & Research

Natera (NTRA)

Applies personalized molecular testing across reproductive health, oncology, and organ health.

$391.02
After hours+0.28 (+0.07%)
At close$390.74(+5.42%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue268311368413440476502547592666697753
Cost of revenue147151159170168176185200208219245268
Gross profit121160209243272300317347384447451485
232244283287311364396457482470545561
Research & development7783898997129129146173175211228
Selling, general & administrative155161194198214235267311309291328327
Other expenses000000000366
Operating income−111−85−74−44−39−65−79−110−98−23−94−76
2777810121010999
Interest income5101010121113111124109
Interest expense333331111711
Other non-operating income−5−10−10−10−12−11−13−11−11−17−8−9
Income before tax−109−78−67−37−31−55−67−101−87−13−85−67
Income tax expense00011−1000−6100
Net income from continuing operations−109−78−68−37−32−54−67−101−8847−85−67
Net income−109−78−68−37−32−54−67−101−8847−85−67
EPS, basic−$0.95−$0.65−$0.56−$0.30−$0.26−$0.41−$0.50−$0.74−$0.64$0.35−$0.60−$0.47
EPS, diluted−$0.95−$0.65−$0.56−$0.30−$0.26−$0.41−$0.50−$0.74−$0.64$0.35−$0.60−$0.47
Weighted average shares, basic115119121123124125135136137137142143
Weighted average shares, diluted115119121123124125135136137137142143
EBITDA−95−64−53−26−20−46−57−90−768−65−45
Depreciation & amortization11101188891010142021
EBIT−106−75−64−33−28−54−66−100−86−6−86−66